Bicycle Therapeutics (BCYC) Total Liabilities (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Total Liabilities data on file, last reported at $98.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 31.68% year-over-year to $98.1 million; the trailing twelve-month figure through Mar 2026 stood at $98.1 million (down 31.68% YoY), and the FY2025 full-year result was $107.6 million, down 34.3% from the prior year.
• Total Liabilities for Q1 2026 stood at $98.1 million, down from $107.6 million in the prior quarter.
• Across five years, Total Liabilities topped out at $234.1 million in Q2 2023 and bottomed at $98.1 million in Q1 2026.
• The 5-year median for Total Liabilities is $163.3 million (2025), against an average of $162.3 million.
• The widest annual swing landed in 2023, when Total Liabilities soared 74.56%; it then slumped 34.3% in 2025.
• A 5-year view of Total Liabilities shows it stood at $139.8 million in 2022, then surged by 60.49% to $224.4 million in 2023, then decreased by 27.01% to $163.8 million in 2024, then plunged by 34.3% to $107.6 million in 2025, then decreased by 8.87% to $98.1 million in 2026.
• The last three Total Liabilities figures came in at $98.1 million (Q1 2026), $107.6 million (Q4 2025), and $145.5 million (Q3 2025), per Business Quant data.

Peer Comparison